Literature DB >> 17107227

Adolescent substance abuse and psychiatric comorbidities.

Deborah Deas1, E Sherwood Brown.   

Abstract

The use and abuse of substances-including alcohol, nicotine, marijuana, inhalants, and other drugs-are commonly found to be comorbid with psychiatric conditions in adolescents. This dual diagnosis requires special attention and treatment, especially as substance use often begins during this developmental period. Adolescents may be diagnosed with substance abuse, substance dependence, or substance use disorder not otherwise specified, which indicates a developing substance use problem that includes symptoms of but does not meet criteria for substance dependence. Psychiatric comorbidity in adolescents who abuse substances is the rule rather the exception, and common comorbidities include depression, anxiety, bipolar disorder, conduct disorder, and attention-deficit/hyperactivity disorder. Treatment of the psychiatric disorder often helps to alleviate the substance use disorder as well. This activity discusses the epidemiology, assessment, and treatment of this dual diagnosis.

Entities:  

Mesh:

Year:  2006        PMID: 17107227     DOI: 10.4088/jcp.0706e02

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  27 in total

1.  Association of ADAM10 and CAMK2A polymorphisms with conduct disorder: evidence from family-based studies.

Authors:  Xue-Qiu Jian; Ke-Sheng Wang; Tie-Jian Wu; Joel J Hillhouse; Jerald E Mullersman
Journal:  J Abnorm Child Psychol       Date:  2011-08

2.  An Australian twin study of cannabis and other illicit drug use and misuse, and other psychopathology.

Authors:  Michael T Lynskey; Arpana Agrawal; Anjali Henders; Elliot C Nelson; Pamela A F Madden; Nicholas G Martin
Journal:  Twin Res Hum Genet       Date:  2012-07-09       Impact factor: 1.587

3.  Reductions in anxiety and depression symptoms in youth receiving substance use treatment.

Authors:  Viviana E Horigian; Carl F Weems; Michael S Robbins; Daniel J Feaster; Jessica Ucha; Michael Miller; Robert Werstlein
Journal:  Am J Addict       Date:  2013 Jul-Aug

4.  Linguistic Predictors of Problematic Drinking in Alcohol-related Facebook Posts.

Authors:  Lyn M van Swol; Chen-Ting Chang; Bradley Kerr; Megan Moreno
Journal:  J Health Commun       Date:  2020-02-25

5.  Further evidence of an association between adolescent bipolar disorder with smoking and substance use disorders: a controlled study.

Authors:  Timothy E Wilens; Joseph Biederman; Joel J Adamson; Aude Henin; Stephanie Sgambati; Martin Gignac; Robert Sawtelle; Alison Santry; Michael C Monuteaux
Journal:  Drug Alcohol Depend       Date:  2008-03-17       Impact factor: 4.492

6.  Consumption of a high-fat diet in adulthood ameliorates the effects of neonatal parathion exposure on acetylcholine systems in rat brain regions.

Authors:  Theodore A Slotkin; T Leon Lassiter; Ian T Ryde; Nicola Wrench; Edward D Levin; Frederic J Seidler
Journal:  Environ Health Perspect       Date:  2009-02-03       Impact factor: 9.031

Review 7.  Corticotropin-Releasing Factor (CRF) Neurocircuitry and Neuropharmacology in Alcohol Drinking.

Authors:  Allyson L Schreiber; Nicholas W Gilpin
Journal:  Handb Exp Pharmacol       Date:  2018

8.  Effects on substance use outcomes in adolescents receiving motivational interviewing for smoking cessation during psychiatric hospitalization.

Authors:  Richard A Brown; David R Strong; Ana M Abrantes; Mark G Myers; Susan E Ramsey; Christopher W Kahler
Journal:  Addict Behav       Date:  2009-03-11       Impact factor: 3.913

9.  CRF1 receptor signaling regulates food and fluid intake in the drinking-in-the-dark model of binge alcohol consumption.

Authors:  William J Giardino; Andrey E Ryabinin
Journal:  Alcohol Clin Exp Res       Date:  2013-02-07       Impact factor: 3.455

Review 10.  Glutamatergic substrates of drug addiction and alcoholism.

Authors:  Justin T Gass; M Foster Olive
Journal:  Biochem Pharmacol       Date:  2007-06-30       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.